We use cookies to improve site performance and enhance your user experience. If you'd like to disable cookies on this device, please see our cookie management page.
If you close this message or continue to use this site, you consent to our use of cookies on this devise in accordance with our cookie policy, unless you disable them.

Close

Find a share

Search for UK shares

Search

Market movers

United Kingdom
movers are constituents of the FTSE 350.
% GainersCompany
content
IC ViewLastChange
Hochschild Mining PLC
HOC:LSE
167.80
GBX
+4.50
+2.76%
N Brown Group PLC
BWNG:LSE
447.50
GBX
+10.00
+2.29%
Aviva PLC
AV.:LSE
526.00
GBX
+10.00
+1.94%
Lloyds Banking Group PLC
LLOY:LSE
76.09
GBX
+1.27
+1.70%
J D Wetherspoon PLC
JDW:LSE
754.50
GBX
+12.50
+1.68%
Cranswick PLC
CWK:LSE
1,345
GBX
+22.00
+1.66%
Centamin PLC
CEY:LSE
65.75
GBX
+1.05
+1.62%
PayPoint PLC
PAY:LSE
1,080
GBX
+17.00
+1.60%
Just Eat PLC
JE.:LSE
269.10
GBX
+4.10
+1.55%
Burberry Group PLC
BRBY:LSE
1,455
GBX
+21.00
+1.46%
As of Sep 02 2014 16:35 BST.

Companies news

Who bought who
Deal status
Deal value
Date
Samsung Heavy Industries Co LtdacquiredSamsung Engineering Co LtdAnnounced2.54bn01 Sep 2014
D & L Industries IncacquiredChemrez Technologies IncAnnounced116.88m01 Sep 2014
Steadfast Group LtdacquiredCalliden Group LtdAnnounced87.82m27 Aug 2014
Fairfax Financial Holdings LtdacquiredPethealth IncAnnounced78.11m29 Aug 2014
Intrepid Mines LtdacquiredBlackthorn Resources LtdAnnounced42.26m28 Aug 2014
1-5 of 6 results

Companies news

Financial Times articles may require a separate login and/or subscription to FT.com

Fears grow over possible Home Depot breach
Netflix calls on Batman for global push
Trafigura sells assets near Texas port
Jefferies revenues hit record $835m
BP tries to remove oil spill claims chief

Featured company

Epistem Holdings PLCEHP:LSE

Epistem Holdings Plc (Epistem) is a United Kingdom-based biotechnology company focusing on epithelial stem cells in the areas of oncology, gastrointestinal disease, dermatology and ageing

© Thomson Reuters Click for restrictions.

All markets data located on Investors Chronicle is subject to the Investors Chronicle Terms & Conditions.

All content on Investors Chronicle is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by Investors Chronicle and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Conditions.

Advertiser reports

Register today and get...

Register today and get...
Please note terms & conditions apply